Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Nov. 30, 2014	Nov. 30, 2013
Net loss	$ (1,412,935)	$ (204,325)
Gain on Settlement of Debts	393,232
Debt Conversion Inducement (Income) Expense	201,849
Interest expense related to derivatives		57,950
Gain on change in fair value of derivatives liability		(61,629)
Shares issued for Consulting expense	284,990
Increase in prepaid expenses	(54,500)
Increase in accrued expenses and other current liabilities	1,131,771	154,211
Net cash used in operating activities	(242,057)	(53,793)
Acquisition In Process Research and development	(224,103)
Net cash used in investing activities	(224,103)
Proceeds of notes payable stockholder	425,152	54,208
Proceeds of notes payable	50,000
Net cash provided by financing activities	475,152	54,208
Increase in cash	8,992	415
Cash- beginning of period	7,047	2,178
Cash - end of period	16,039	2,593
Non cash component of prepaid	569,892
Conversion of current liabilities to common stock	1,102,697
Conversion of notes payable to common stock		12,000
Debt discount in notes payable		(57,950)
Notes payable stockholders	1,342,785
Non cash component of acquisition In Process Research & development	4,400,000
Non cash component of stock issued for In Process Research & development acquisition	$ (4,400,000)